Sol Gel Technologies (NASDAQ:SLGL) Issues Earnings Results
Sol Gel Technologies (NASDAQ:SLGL) announced its earnings results on Tuesday. The company reported ($0.26) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.32) by $0.06, Fidelity Earnings reports. The firm had revenue of $7.79 million during the quarter, compared to analysts’ expectations of $7.00 million. Sol Gel Technologies had a negative return on equity of 64.21% and a negative net margin of 686.02%.
Shares of SLGL stock traded up $0.30 during trading hours on Wednesday, reaching $8.60. 150 shares of the company’s stock were exchanged, compared to its average volume of 17,478. Sol Gel Technologies has a fifty-two week low of $5.41 and a fifty-two week high of $11.36. The company has a market capitalization of $161.41 million, a PE ratio of -4.74 and a beta of 0.51. The business’s fifty day simple moving average is $9.57. The company has a quick ratio of 8.29, a current ratio of 8.29 and a debt-to-equity ratio of 0.01.
SLGL has been the subject of a number of research analyst reports. Zacks Investment Research lowered Sol Gel Technologies from a “buy” rating to a “hold” rating in a report on Friday, July 19th. HC Wainwright upped their price target on Sol Gel Technologies from $21.00 to $23.00 and gave the stock a “buy” rating in a report on Tuesday, July 9th. Finally, ValuEngine lowered Sol Gel Technologies from a “buy” rating to a “hold” rating in a report on Thursday, August 1st.
Sol-Gel Technologies Ltd., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include TWIN and SIRS-T, which has completed Phase II clinical trials for the treatment of acne vulgaris; and VERED that has completed Phase II clinical trials for the treatment of papulopustular rosacea.
Featured Article: How much can an individual set aside as a catch-up contribution?
Receive News & Ratings for Sol Gel Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sol Gel Technologies and related companies with MarketBeat.com's FREE daily email newsletter.